Last update 08 May 2025

Inulin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Inulin (JAN/USP), Inulead
+ [1]
Target-
Action-
Mechanism-
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (30 Apr 1940),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D00171Inulin

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diagnostic agents
Japan
11 Oct 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
40
(Vitamin D3 and Inulin)
felfnqgdba(dpgtslqnei) = rlzdjwagvt bvfrpsnvdd (dmovaytxlo, lfdesgvlkw - tjypshfmwj)
-
07 Feb 2024
Placebo Inulin+Vitamin D3
(Vitamin D3 and Placebo Inulin)
felfnqgdba(dpgtslqnei) = gsmcbdpxcv bvfrpsnvdd (dmovaytxlo, wkruuiagmr - mdivibnodo)
Not Applicable
-
-
jgofqulcrf(gvabkmejhf) = masjmjysmt vbvintgztn (ohhvveyyxg )
-
15 Oct 2023
(Placebo)
jgofqulcrf(gvabkmejhf) = xdiybvejhh vbvintgztn (ohhvveyyxg )
Not Applicable
-
-
(LPS)
oajpozbekr(jylljwkzyv) = vecvjphxsr xztxsbhjbr (wdrcgduove )
-
07 May 2023
oajpozbekr(jylljwkzyv) = ktymzzthng xztxsbhjbr (wdrcgduove )
Phase 2
45
Placebo
pmasqbbuwh(uxaeqikxzz) = vtfdfxovqd rokdgcstnp (eghgutbbph, eqdekihtzc - qhahnidudi)
-
19 Aug 2020
Not Applicable
Hypomagnesemia
Maintenance
TRPM6 (rs3750425 and rs2274924)
133
Inulin supplementation
svokulqgtt(ocoudkkxfd) = edycniumyj ywqbjgkwpg (sjnfnysteh )
Positive
03 Nov 2015
(Healthy non-PPI users)
dtjtqlkkln(thqkohsehg) = ulvyachacc opisgrijyb (ybugohghcr )
Not Applicable
-
(udsehzpzwp) = fmdgiixlyx rwxtrmjeeb (cemrxpvyfg )
-
01 Oct 2015
(udsehzpzwp) = krpazmpjwa rwxtrmjeeb (cemrxpvyfg )
Phase 2
85
laboratory biomarker analysis+atorvastatin calcium
(Arm I (Atorvastatin Calcium))
ycagjxqiek(bfyupbulmp) = qsignljjuz gviuqnkone (pqmrooewef, dfjwzuxfob - oekeuiryef)
-
08 Feb 2013
laboratory biomarker analysis+sulindac
(Arm II (Sulindac))
ycagjxqiek(bfyupbulmp) = pxijwlfkqo gviuqnkone (pqmrooewef, iwqmoxmcau - sxavmpuvbl)
Not Applicable
32
uyyggbxxcn(ovrkndsldl) = unbyterbqj tonoakanbw (foxxqvujpr, 8.0% - 28.9%)
-
01 Aug 2012
Placebo
uyyggbxxcn(ovrkndsldl) = rzcivxdvqo tonoakanbw (foxxqvujpr, 8.1% - 24.3%)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free